Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells
- PMID: 10340380
- DOI: 10.1038/sj.onc.1202647
Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells
Abstract
In CCL39 cells thrombin is a potent growth factor which requires sustained activation of mitogen activated protein kinases (MAPKs) to promote DNA synthesis. Some of the effects of thrombin can be mimicked by peptides based on the new amino terminus of the cleaved receptor; however, these thrombin receptor peptides (TRPs) fail to induce sustained activation of MAPK or DNA synthesis. We have used thrombin, TRP-7 and other agonists which elicit sustained or transient MAPK activation to identify immediate-early and delayed-early genes which are only expressed under conditions of sustained MAPK activation focusing on cyclin D1, p21CiP1 and the AP-1 transcription factor. Of the stimuli tested only FBS and thrombin were able to stimulate a sustained activation of MAPK, expression of cyclin D1, p21Cip1 and cell cycle re-entry. The expression of cyclin D1 was strongly, though not completely, inhibited by the MEK1 inhibitor PD098059. Thrombin stimulated a rapid but transient accumulation of c-Fos whereas the expression of Fra-1, Fra-2, c-Jun and JunB was sustained throughout the G1 phase of the cell cycle. We focussed our analysis on c-Fos (typical of AP-1 genes which are expressed rapidly and transiently) and Fra-1 and JunB (typical of AP-1 genes expressed after a delay but in a sustained manner). The expression of c-Fos, Fra-1 and JunB was dependent upon the activation of MAPK since these responses were inhibited by PD098059. However, a comparison of responses to FBS, thrombin, TRPs, LPA and EGF revealed that Fra-1 and JunB expression required sustained activation of MAPK whereas c-Fos expression was strongly induced even by non-mitogenic stimuli which elicited only transient MAPK activation. The expression of c-Fos (in response to thrombin, TRP or LPA) or Fra-1, JunB and cyclin D1 (thrombin only) was also inhibited by pertussis toxin. This suggests that both early and late AP-1 gene expression is regulated by the same Gi-mediated, MEK-dependent MAPK signalling pathway but that expression of late AP-1 genes and cyclin D1 requires that this pathway be persistently activated. The results suggest that the duration of receptor signalling and therefore MAPK activation is a key determinant of qualitative changes in gene expression during cell cycle re-entry.
Similar articles
-
The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.Mol Cell Biol. 1999 Jan;19(1):330-41. doi: 10.1128/MCB.19.1.330. Mol Cell Biol. 1999. PMID: 9858557 Free PMC article.
-
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.J Biol Chem. 1996 Aug 23;271(34):20608-16. doi: 10.1074/jbc.271.34.20608. J Biol Chem. 1996. PMID: 8702807
-
An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.Oncogene. 1998 Sep 10;17(10):1271-7. doi: 10.1038/sj.onc.1202057. Oncogene. 1998. PMID: 9771970
-
Regulation of cell cycle entry and G1 progression by CSF-1.Mol Reprod Dev. 1997 Jan;46(1):11-8. doi: 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U. Mol Reprod Dev. 1997. PMID: 8981358 Review.
-
Mitogenic effects of fibroblast growth factors in cultured fibroblasts. Interaction with the G-protein-mediated signaling pathways.Ann N Y Acad Sci. 1991;638:139-48. doi: 10.1111/j.1749-6632.1991.tb49024.x. Ann N Y Acad Sci. 1991. PMID: 1664681 Review.
Cited by
-
ERK MAP kinase in G cell cycle progression and cancer.Cancer Sci. 2006 Aug;97(8):697-702. doi: 10.1111/j.1349-7006.2006.00244.x. Epub 2006 Jun 23. Cancer Sci. 2006. PMID: 16800820 Free PMC article. Review.
-
Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.Cells. 2021 Nov 26;10(12):3327. doi: 10.3390/cells10123327. Cells. 2021. PMID: 34943835 Free PMC article. Review.
-
Remuscularization with triiodothyronine and β1-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling.Sci Rep. 2022 May 25;12(1):8852. doi: 10.1038/s41598-022-12723-2. Sci Rep. 2022. PMID: 35614155 Free PMC article.
-
PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells.J Cancer. 2015 Oct 29;6(12):1320-30. doi: 10.7150/jca.11126. eCollection 2015. J Cancer. 2015. PMID: 26640592 Free PMC article.
-
Reactive oxygen species-dependent signaling regulates cancer.Cell Mol Life Sci. 2009 Dec;66(23):3663-73. doi: 10.1007/s00018-009-0099-y. Epub 2009 Jul 24. Cell Mol Life Sci. 2009. PMID: 19629388 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous